Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer.
about
High motivation for exercise is associated with altered chromatin regulators of monoamine receptor gene expression in the striatum of selectively bred mice.DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathwayMicelle-enhanced direct spectrofluorimetric method for the determination of linifanib: Application to stability studies.Thymoquinone induces cytotoxicity and reprogramming of EMT in gastric cancer cells by targeting PI3K/Akt/mTOR pathway.Association of Vascular Endothelial Growth Factor ( VEGF) Gene Polymorphisms With Gastric Cancer and Its Development, Prognosis, and Survival.A novel computational approach for drug repurposing using systems biology.
P2860
Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Linifanib (ABT-869) Potentiate ...... ng Pathways in Gastric Cancer.
@en
type
label
Linifanib (ABT-869) Potentiate ...... ng Pathways in Gastric Cancer.
@en
prefLabel
Linifanib (ABT-869) Potentiate ...... ng Pathways in Gastric Cancer.
@en
P2093
P2860
P356
P1433
P1476
Linifanib (ABT-869) Potentiate ...... ing Pathways in Gastric Cancer
@en
P2093
Jiawei Guo
Jieqiong Wang
Xiufeng Pang
P2860
P2888
P356
10.1038/SREP29382
P407
P50
P577
2016-07-08T00:00:00Z